Regulation of p38 MAP kinase by anastellin is independent of anastellin's effect on matrix fibronectin

Matrix Biology

Volumn 28, Issue 2, 2009, Pages 101-109

  You, Ran ^a   Klein, R Matthew ^a   Zheng, Mingzhe ^a   McKeown Longo, Paula J ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Anastellin; Extracellularmatrix; Fibronectin; MAP kinase

Indexed keywords

ANASTELLIN; ANGIOGENESIS INHIBITOR; BETA1 INTEGRIN; FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE P38; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME REGULATION; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING;

ANALYSIS OF VARIANCE; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBRONECTINS; HUMANS; IMMUNOBLOTTING; MICROSCOPY, FLUORESCENCE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS;

EID: 62749158976     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.matbio.2009.01.003     Document Type: Article

References (41)

1. Akerman M.E., Pilch J., Peters D., and Ruoslahti E. Angiostatic peptides use plasma fibronectin to home to angiogenic vasculature. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 2040-2045
2. Ambesi A., Klein R.M., Pumiglia K.M., and McKeown-Longo P.J. Anastellin, a fragment of the first type III repeat of fibronectin, inhibits extracellular signal-regulated kinase and causes G1 arrest in human microvessel endothelial cells. Cancer Res. 65 (2005) 148-156
3. Baneyx G., Baugh L., and Vogel V. Coexisting conformations of fibronectin in cell culture imaged using fluorescence resonance energy transfer. Proc. Natl. Acad. Sci. 98 (2001) 14464-14468
4. Baneyx G., Baugh L., and Vogel V. Fibronectin extension and unfolding within cell matrix fibrils controlled by cytoskeletal tension. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 14464-14468
5. Berrier A.L., and Yamada K.M. Cell-matrix adhesion. J. Cell Physiol. 213 (2007) 565-573
6. Bourdoulous S., Orend G., MacKenna D.A., Pasqualini R., and Ruoslahti E. Fibronectin matrix regulates activation of RHO and CDC42 GTPases and cell cycle progression. J. Cell Biol. 143 (1998) 267-276
7. Brideau G., Makinen J.J., Elamaa H., Tu H., Nilsson G., Alitalo K., Pihlajaniemi T., and Heljasvaara R. Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice. Cancer Res. 67 (2007) 11528-11535
8. Briknarova K., Akerman M.E., Hoyt D.W., Ruoslahti E., and Ely K.R. Anastellin, an FN3 fragment with fibronectin polymerization activity, resembles amyloid fibril precursors. J. Mol. Biol. 332 (2003) 205-215
9. Chen H., and Mosher D.F. Formation of sodium dodecyl sulfate-stable fibronectin multimers. J. Biol. Chem. 271 (1996) 9084-9089
10. Christopher R.A., Kowalczyk A.P., and McKeown-Longo P.J. Localization of fibronectin matrix assembly sites on fibroblasts and endothelial cells. J. Cell Sci. 110 (1997) 569-581
11. Deno D.C., Saba T.M., and Lewis E.P. Kinetics of endogenously labeled plasma fibronectin: incorporation into tissues. Am. J. Physiol. 245 (1983) R564-R575
12. Gao M., Craig D., Lequin O., Campbell I.D., Vogel V., and Schulten K. Structure and functional significance of mechanically unfolded fibronectin type III1 intermediates. Proc. Natl. Acad. Sci. 100 (2003) 14784-14789
13. Ginsberg M.H., Partridge A., and Shattil S.J. Integrin regulation. Curr. Opin. Cell Biol. 17 (2005) 509-516
14. Hocking D.C., and Chang C.H. Fibronectin matrix polymerization regulates small airway epithelial cell migration. Am. J. Physiol. Lung Cell. Mol. Physiol. 285 (2003) L169-L179
15. Hocking D.C., Sottile J., and McKeown-Longo P.J. Fibronectin's III-1 module contains a conformation-dependent binding site for the amino-terminal region of fibronectin. J. Biol. Chem. 269 (1994) 19183-19191
16. Hocking D.C., Smith R.K., and McKeown-Longo P.J. A novel role for the integrin-binding III-10 module in fibronectin matrix assembly. J. Cell Biol. 133 (1996) 431-444
17. Hocking D.C., Sottile J., Reho T., Fassler R., and McKeown-Longo P.J. Inhibition of fibronectin matrix assembly by the heparin-binding domain of vitronectin. J. Biol. Chem. 274 (1999) 27257-27264
18. Hocking D.C., Titus P.A., Sumagin R., and Sarelius I.H. Extracellular matrix fibronectin mechanically couples skeletal muscle contraction with local vasodilation. Circ. Res. 102 (2008) 372-379
19. Isayeva T., Chanda D., Kallman L., Eltoum I.E., and Ponnazhagan S. Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP model. Cancer Res. 67 (2007) 5789-5797
20. Klein R.M., Zheng M., Ambesi A., van de Water L., and McKeown-Longo P.J. Stimulation of extracellular matrix remodeling by the first type III repeat in fibronectin. J. Cell Sci. 116 (2003) 4663-4674
21. Larsen M., Artym V.V., Green J.A., and Yamada K.M. The matrix reorganized: extracellular matrix remodeling and integrin signaling. Curr. Opin. Cell Biol. 18 (2006) 463-471
22. Li D., Mukai K., Suzuki T., Suzuki R., Yamashita S., Mitani F., and Suematsu M. Adrenocortical zonation factor 1 is a novel matricellular protein promoting integrin-mediated adhesion of adrenocortical and vascular smooth muscle cells. FEBS J. 374 (2007) 2506-2522
23. Litvinovich S.V., Brew S.A.A.S., Akiyama S.K., Haudenschild C., and Ingham K.C. Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module. J. Mol. Biol. 280 (1998) 245-258
24. Mao Y., and Schwarzbauer J.E. Stimulatory effects of a three-dimensional microenvironment on cell-mediated fibronectin fibrillogenesis. J. Cell Sci. 118 (2005) 4427-4436
25. Mercurius K., and Morla A. Cell adhesion and signaling on the fibronectin 1st type III repeat; requisite roles for cell surface proteoglycans and integrins. BMC Cell Biol. 2 (2001) 18-30
26. Morla A., Zhang Z., and Ruoslahti E. Superfibronectin is a functionally distinct form of fibronectin. Nature 367 (1994) 193-196
27. Nyberg P., Xie L., and Kalluri R. Endogenous inhibitors of angiogenesis. Cancer Res. 65 (2005) 3967-3979
28. Ohashi T., and Erickson H.P. Domain unfolding plays a role in superfibronectin formation. J. Biol. Chem. 280 (2005) 39143-39151
29. Ohashi T., Kiehrat D.P., and Erickson H.P. Dynamics and elasticity of the fibronectin matrix in living cell culture visualized by fibronectin-green fluorescent protein. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 2153-2158
30. Pasqualini R., Bourdoulous S., Looivunen E., Woods Jr. V.L., and Ruoslahti E. A polymeric form of fibronectin has antimetastatic effects against multiple tumor types. Nat. Med. 2 (1996) 1197-1203
31. Rebres R.A., McKeown-Longo P.J., Vincent P.A., Cho E., and Saba T.M. Extracellular matrix incorporation of normal and NEM-alkylated plasma fibronectin: liver and spleen deposition. Am. J. Physiol. 269 (1995) G902-G912
32. Schor S.L., Ellis I.R., Jones S., Baillie R., Seneviratne K., Clausen J., Motegi K., Vojtesek B., Kanova K., Furrie E., Sales M.J., Schor A.M., and Kay R.A. Migration-stimulating factor: a genetically truncated onco-fetal fibronectin isoform expressed by carcinoma and tumor-associated stromal cells. Cancer Res. 63 (2003) 8827-8836
33. Sechler J.L., Rao H., Cumiskey A.M., Vega-Colon I., Smith M.S., Murata T., and Schwarzbauer J.E. A novel fibronectin binding site required for fibronectin fibril growth during matrix assembly. J. Cell Biol. 154 (2001) 1081-1088
34. Sottile J., Hocking D.C., and Swiatek P.J. Fibronectin matrix assembly enhances adhesion-dependent cell growth. J. Cell Sci. 111 (1998) 2933-2943
35. Tellier M.C., Greco G., Klotman M., Mosoian A., Cara A., Arap W., Ruoslahti E., Pasqualini R., and Schnapp L.M. Superfibronectin, a multimeric form of fibronectin, increases HIV infection of primary CD4+ T lymphocytes. J. Immunol. 164 (2000) 3236-3245
36. Thompson C., Blumenstock F.A., Saba T.M., Feustel P.J., Kaplan J.E., Fortune J.B., Hough L., and Gray V. Plasma fibronectin synthesis in normal and injured humans as determined by stable isotope incorporation. J. Clin. Invest. 84 (1989) 1226-1235
37. Wickstrom S.A., Keski-Oja J., and Alitalo K. Matrix reloaded to circulation hits the tumor target. Cancer Cell 3 (2003) 513-514
38. Yi M., and Ruoslahti E. A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis. Proc. Natl. Acad. Sci. 98 (2001) 620-624
39. Zheng M., and McKeown-Longo P.J. Regulation of HEF1 expression and phosphorylation by TGF-b1 and cell adhesion. J. Biol. Chem. 277 (2002) 39599-39608
40. Zheng M., Ambesi A., Yu L., and McKeown-Longo P.J. Quantification of fibronectin matrix assembly sites using a novel ELISA assay. Matrix Biol. 26 (2007) 330-333
41. Zhong C., Chrzanowska-Wodnicka M., Brown J., Shaub A., Belkin A.M., and Burridge K. Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly. J. Cell Biol. 141 (1998) 539-551